CERILLIANT™ Everolimus-D4 Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™
Certified reference material
Manufacturer: MilliporeSigma Supelco E0701ML
DescriptionA stable-labeled internal standard for the immunosuppressant Everolimus, marketed as Zortress™ and Certican for use in organ transplantation and Afinitor™ for treatment of kidney and pancreatic cancers. Clinical laboratories quantitate everolimus levels in patient whole blood samples using LC-MS/MS. While many everolimus LC-MS/MS methods use 32-desmethoxyrapamycin or ascomycin as an internal standard, higher levels of variability / lower levels of reproducibility may occur in the analysis along with the potential for interferences. Use of a stable-labeled analog of everolimus is the best choice to minimize variability or mitigate any potential interference in LC-MS/MS analysis.
|UN 1648 3 / PGII|
|2°C (35.6°F) - closed cup|
|100 μg/mL in acetonitrile|
Safety and Handling
EINECSNumber : 200-835-2
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok
CERILLIANT is a registered trademark of Cerilliant Corporation